

Author: Yoshihara Kazutaka
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.44, Iss.12, 2005-01, pp. : 1329-1342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension
Pediatric Drugs, Vol. 14, Iss. 6, 2012-12 ,pp. :




Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. :




Olmesartan Medoxomil: A Review of its Use in the Management of Hypertension
By Scott Lesley J. McCormack Paul L.
Drugs, Vol. 68, Iss. 9, 2008-01 ,pp. :